pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 789 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    LP-118
    Anaplastic Large Cell Lymphoma (ALCL) Newave Pharmaceutical Co Ltd
  • Phase 1
    LP-284
    B-Cell Non-Hodgkin Lymphoma$LTRN Lantern Pharma Inc.
  • Phase 1
    LP-410
    tacrolimus
    Graft Versus Host Disease (GVHD)$LIPO LIPELLA PHARMACEUTICALS INC.
← prev
page 14 of 27
next →
131
Pain89
Neurology1
Phase 1
LPAR1 Antagonists
Fibrosis
Viva Star Biosciences (Suzhou) Co Ltd
  • Phase 1
    LPXTI-641
    Psoriatic Arthritis Lapix Therapeutics Inc
  • Phase 1
    LR-19018
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… LG Chem Ltd
  • Phase 1
    LR-19123
    Type 2 Diabetes LG Chem Ltd
  • Phase 1
    LR-19155
    Head And Neck Squamous Cell Carcinoma (HNSC) LG Chem Ltd
  • Phase 1
    LS-01
    Esophageal Squamous Cell Carcinoma (ESCC) Guangzhou Liushun Biotechnology Co Ltd
  • Phase 1
    LSLBP-002
    Renal Cell Carcinoma Shanghai Lishan Biopharmaceuticals Co Ltd
  • Phase 1
    LTZ-301
    Diffuse Large B-Cell Lymphoma LTZ Therapeutics Inc
  • Phase 1
    LYL-273
    Metastatic Colorectal Cancer$LYEL Lyell Immunopharma, Inc.
  • Phase 1
    LZ-001
    Non-Small Cell Lung Cancer Livzon Pharmaceutical Group Inc
  • Phase 1
    MB-101
    Brain Tumor$MBIO MUSTANG BIO, INC.
  • Phase 1
    MB-108
    Anaplastic Astrocytoma$MBIO MUSTANG BIO, INC.
  • Phase 1
    MBP-134
    Ebolavirus Infections (Ebola Hemorrhagic Fever) Mapp Biopharmaceutical Inc
  • Phase 1
    MBQ-167
    Triple-Negative Breast Cancer (TNBC) MBQ Pharma Inc
  • Phase 1
    MBX-4291
    Obesity$MBX MBX Biosciences, Inc.
  • Phase 1
    MCLA-145
    Solid Tumor Merus NV
  • Phase 1
    MCM-998
    Multiple Myeloma (Kahler Disease)$NVS NOVARTIS AG
  • Phase 1
    MDX-2301
    Coronavirus Disease 2019 (COVID-19) ModeX Therapeutics Inc
  • Phase 1
    MEB-1170
    Pain Mebias Discovery LLC
  • Phase 1
    MEI-004
    Alopecia Nanjing Mainowei Pharmaceutical Technology Co Ltd.
  • Phase 1
    MEM-288
    Cutaneous Squamous Cell Carcinoma (cSCC) Memgen Inc
  • Phase 1
    MEN-2312
    Hematological Tumor Stemline Therapeutics Inc
  • Phase 1
    MEN-2501
    Fallopian Tube Cancer Stemline Therapeutics Inc
  • Phase 1
    MF-300
    Sarcopenia Epirium Bio Inc
  • Phase 1
    MGC-028
    Bile Duct Cancer (Cholangiocarcinoma)$MGNX MACROGENICS INC
  • Phase 1
    MGD-024
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$MGNX MACROGENICS INC
  • Phase 1
    MO-03
    Metastatic Renal Cell Carcinoma Osel Inc